Initially housing around 20 employees, the facility provides capacity for planned headcount growth over the next 12 months as part of Noblegen’s ongoing investment in the UK.
Chris Harvey, General Manager, said:
“As a global leader in liquid nitrogen generator manufacturing, this new facility gives us the ideal platform to build on our success. We’ve invested heavily in our team and processes, accelerating R&D while creating space for future expansion. This is a cornerstone of our growth strategy—leveraging Peak International Group’s worldwide sales and service networks to make on-demand liquid nitrogen generation accessible to a broader market.”
While primarily serving research facilities, Noblegen has expanded into healthcare, dermatology, IVF clinics, animal husbandry, NMR spectroscopy, and pharmaceutical testing. This growth is supported by Peak International Group, a gas generation leader with two decades of laboratory gas market expertise. Their backing has fuelled Noblegen’s expansion, with increased investments in operations, R&D, business development, and the new facility.
Chris added: “This move prepares us for ambitious growth, enabling faster product development and providing a collaborative workspace that drives innovation. Scaling production opens doors to previously untapped markets—dermatology clinics, hospitals, universities, and beyond.”
Noblegen is excited to enter this new chapter, making on-demand liquid nitrogen generation accessible to a wider market and positioning the company for significant global growth.